MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Biocept Cash and Cash Equivalents 2011-2026 | BIOC
Annual Cash and Cash Equivalents Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.9 M | 28.9 M | 14.4 M | 9.3 M | 3.42 M | 2.15 M | 4.61 M | 8.82 M | 5.36 M | 69.2 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 28.9 M | 69.2 K | 8.99 M |
Quarterly Cash and Cash Equivalents Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.63 M | 6.77 M | 12.9 M | 18 M | 22.9 M | 27.6 M | 28.9 M | 27.7 M | 19.5 M | 14.2 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 4.61 M | 679 K | 3.75 M | 4.57 M | 8.82 M | 12.5 M | 8.82 M | 8.82 M | 5.36 M | 5.36 M | 5.36 M | 5.36 M | 69.2 K | 69.2 K | 69.2 K | 69.2 K | 185 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.9 M | 69.2 K | 8.76 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
69.3 M | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Co-Diagnostics
CODX
|
14.9 M | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Danaher Corporation
DHR
|
2.08 B | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
566 M | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
BioNano Genomics
BNGO
|
9.17 M | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
36.8 M | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
IQVIA Holdings
IQV
|
1.7 B | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
601 M | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
CareDx, Inc
CDNA
|
82.2 M | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
Celcuity
CELC
|
22.5 M | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
Myriad Genetics
MYGN
|
102 M | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
NeoGenomics
NEO
|
367 M | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
National Research Corporation
NRC
|
6.65 M | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Anixa Biosciences
ANIX
|
1.27 M | $ 3.12 | - | $ 99.5 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.4 B | $ 27.08 | -1.13 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
1.5 M | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Personalis
PSNL
|
91.4 M | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | $ 44.97 | -0.77 % | $ 10 B | Niderland |
 |
Guardant Health
GH
|
526 M | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
RadNet
RDNT
|
740 M | $ 71.35 | -0.2 % | $ 5.21 B | USA |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Soleno Therapeutics
SLNO
|
87.9 M | $ 46.3 | 0.02 % | $ 1.86 B | USA |
 |
ENDRA Life Sciences
NDRA
|
3.23 M | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
195 M | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.01 B | $ 579.45 | -0.69 % | $ 221 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.79 | -3.54 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 31.72 | -1.34 % | $ 1.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
549 M | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
26.2 M | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |